UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036235
Receipt number R000040998
Scientific Title Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation in the intentional tooth replantation.
Date of disclosure of the study information 2019/03/17
Last modified on 2019/03/19 09:16:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation in the intentional tooth replantation.

Acronym

Platelet rich plasma transplantation in the intentional tooth replantation.

Scientific Title

Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation in the intentional tooth replantation.

Scientific Title:Acronym

Platelet rich plasma transplantation in the intentional tooth replantation.

Region

Japan


Condition

Condition

Fracture of dental root

Classification by specialty

Oral surgery Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety of Platelet rich plasma transplantation for the intentional tooth replantation.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety

Key secondary outcomes

Scientific validity


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Platelet rich plasma transplantation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A patient MUST:
1) Have a fracture of dental root.
2) Have a tooth which considered to effective by the tooth replantation.
3) Have good systemic condition.
4) Number of platelet is over 1x10E5 /microliter.
5) 20 years and older.
6) Other,the investigator believes makes him/her suitable for participation in this clinical study.

Key exclusion criteria

Patient MUST NOT:
1) Have a separated dental root and have an abscess at the root apical.
2) Have a history of Complicate malignant tumor.
3) Have an abnormal gingival proliferation or having a history of abnormal gingival proliferation.
4) Suspected of oral malignant tumor or precancerous lesion.
5) Under 20 years of old.
6) Have anti-coagulant or anti-platelet medications, or have a bleeding disorders.
7) Pregnancy, breastfeeding, or possibility of pregnancy
8) Other,the investigator believes makes him/her unsuitable for participation in the clinical study.

Target sample size

2


Research contact person

Name of lead principal investigator

1st name Morikuni
Middle name
Last name Tobita

Organization

Juntendo Hospital, Juntendo university school of medicine

Division name

Dental and Oral surgery

Zip code

113-8431

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan

TEL

03-3813-3111

Email

mtobita@juntendo.ac.jp


Public contact

Name of contact person

1st name Morikuni
Middle name
Last name Tobita

Organization

Juntendo Hospital, Juntendo university school of medicine

Division name

Dental and Oral surgery

Zip code

113-8431

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan

TEL

03-3813-3111

Homepage URL


Email

mtobita@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board of Juntendo University Faculty of Medicine

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-3813-3111

Email

rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 03 Month 14 Day

Date of IRB

2019 Year 03 Month 18 Day

Anticipated trial start date

2019 Year 03 Month 18 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 17 Day

Last modified on

2019 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040998


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name